Improving blood vessel function in people with type 1 diabetes
Therapeutic Strategies for Microvascular Dysfunction in Type 1 Diabetes
This study is looking at how blood flow problems in people with type 1 diabetes can affect their heart health, and it will test new treatments to help improve circulation and overall fitness.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Virginia NIH-funded |
| Lab location | 1 site (Charlottesville, United States) |
| Project ID | NIH-10983300 on NIH RePORTER |
What this research studies
This research investigates how microvascular dysfunction affects individuals with type 1 diabetes and explores potential treatments to improve blood flow and overall cardiovascular health. The study focuses on understanding the mechanisms behind insulin resistance and endothelial dysfunction, which are common in type 1 diabetes. By examining the role of oxidative stress and testing adjuvant therapies like GLP-1 receptor agonists, the research aims to enhance muscle microvascular perfusion and cardiorespiratory fitness. Patients may be involved in trials assessing these new therapeutic strategies.
Who could benefit from this research
Good fit: Ideal candidates for this research are adults and youth diagnosed with type 1 diabetes who experience issues related to blood vessel function.
Not a fit: Patients without type 1 diabetes or those with advanced cardiovascular disease may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved cardiovascular health and fitness for individuals with type 1 diabetes.
How similar studies have performed: Previous research has shown promise in using GLP-1 receptor agonists to improve vascular function in related conditions, indicating potential success for this approach.
Where this research is happening
Charlottesville, United States
- University of Virginia — Charlottesville, United States (Active)
Researchers
- Principal investigator: Love, Kaitlin M — University of Virginia
- Study coordinator: Love, Kaitlin M
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.